ZA872167B - Compounds and pharmaceutical preparations having calcium-regulatory activity - Google Patents
Compounds and pharmaceutical preparations having calcium-regulatory activityInfo
- Publication number
- ZA872167B ZA872167B ZA872167A ZA872167A ZA872167B ZA 872167 B ZA872167 B ZA 872167B ZA 872167 A ZA872167 A ZA 872167A ZA 872167 A ZA872167 A ZA 872167A ZA 872167 B ZA872167 B ZA 872167B
- Authority
- ZA
- South Africa
- Prior art keywords
- calcium
- compounds
- pharmaceutical preparations
- regulatory activity
- regulatory
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB868607749A GB8607749D0 (en) | 1986-03-27 | 1986-03-27 | Compounds & pharmaceutical preparations |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA872167B true ZA872167B (en) | 1988-07-27 |
Family
ID=10595392
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA872167A ZA872167B (en) | 1986-03-27 | 1987-03-24 | Compounds and pharmaceutical preparations having calcium-regulatory activity |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0240257A3 (xx) |
JP (1) | JPS62289525A (xx) |
AU (1) | AU7062187A (xx) |
DE (1) | DE240257T1 (xx) |
ES (1) | ES2001147A4 (xx) |
GB (2) | GB8607749D0 (xx) |
IL (1) | IL81990A0 (xx) |
NZ (1) | NZ219771A (xx) |
ZA (1) | ZA872167B (xx) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100430049C (zh) * | 1994-09-09 | 2008-11-05 | 小山省三 | 分子表达功能抑制剂 |
FR2819414A1 (fr) * | 2001-01-15 | 2002-07-19 | Cognis France Sa | Preparations cosmetiques et/ou pharmaceutiques comprenant des extraits de plantes dites a resurrection |
ITTO20050708A1 (it) | 2005-10-07 | 2007-04-08 | Univ Degli Studi Genova | Fluridone come agente anti-infiammatorio |
US7741367B2 (en) * | 2006-02-08 | 2010-06-22 | Virginia Tech Intellectual Properties, Inc. | Method of using abscisic acid to treat diseases and disorders |
US20110054033A1 (en) * | 2009-08-26 | 2011-03-03 | Virginia Tech Intellectual Properties, Inc. | Methods of using abscisic acid for ameliorating hypertension and vascular inflammation |
WO2011150160A2 (en) * | 2010-05-26 | 2011-12-01 | Virginia Tech Intellectual Properties, Inc. | Method of preventing and treating inflammatory diseases and disorders with abscisic acid |
AR085585A1 (es) | 2011-04-15 | 2013-10-09 | Bayer Cropscience Ag | Vinil- y alquinilciclohexanoles sustituidos como principios activos contra estres abiotico de plantas |
AR090010A1 (es) | 2011-04-15 | 2014-10-15 | Bayer Cropscience Ag | 5-(ciclohex-2-en-1-il)-penta-2,4-dienos y 5-(ciclohex-2-en-1-il)-pent-2-en-4-inos sustituidos como principios activos contra el estres abiotico de las plantas, usos y metodos de tratamiento |
AR085568A1 (es) | 2011-04-15 | 2013-10-09 | Bayer Cropscience Ag | 5-(biciclo[4.1.0]hept-3-en-2-il)-penta-2,4-dienos y 5-(biciclo[4.1.0]hept-3-en-2-il)-pent-2-en-4-inos sustituidos como principios activos contra el estres abiotico de las plantas |
AR101214A1 (es) | 2014-07-22 | 2016-11-30 | Bayer Cropscience Ag | Ciano-cicloalquilpenta-2,4-dienos, ciano-cicloalquilpent-2-en-4-inas, ciano-heterociclilpenta-2,4-dienos y ciano-heterociclilpent-2-en-4-inas sustituidos como principios activos contra el estrés abiótico de plantas |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB783611A (en) * | 1954-06-30 | 1957-09-25 | Ici Ltd | Gibberellic acid and derivatives thereof |
NL121956C (xx) * | 1958-11-04 | |||
GB909752A (en) * | 1960-06-27 | 1962-11-07 | Ici Ltd | Gibberellic acid derivative |
GB1073882A (en) * | 1965-04-14 | 1967-06-28 | Shell Int Research | Process for the preparation of biologically active 2,4-pentadienoic acid derivatives |
GB1123487A (en) * | 1966-03-04 | 1968-08-14 | Shell Int Research | Novel organic acid derivatives |
US3958025A (en) * | 1972-10-06 | 1976-05-18 | Livingston Virginia W C | Abscisic acid tablets and process |
US4518614A (en) * | 1982-11-04 | 1985-05-21 | Redken Laboratories, Inc. | Cosmetic preparation |
-
1986
- 1986-03-27 GB GB868607749A patent/GB8607749D0/en active Pending
-
1987
- 1987-03-24 IL IL81990A patent/IL81990A0/xx unknown
- 1987-03-24 ZA ZA872167A patent/ZA872167B/xx unknown
- 1987-03-25 AU AU70621/87A patent/AU7062187A/en not_active Abandoned
- 1987-03-25 NZ NZ219771A patent/NZ219771A/xx unknown
- 1987-03-26 GB GB8707256A patent/GB2193091B/en not_active Expired - Fee Related
- 1987-03-26 JP JP62070553A patent/JPS62289525A/ja active Pending
- 1987-03-26 EP EP87302644A patent/EP0240257A3/en not_active Withdrawn
- 1987-03-26 DE DE198787302644T patent/DE240257T1/de active Pending
- 1987-03-26 ES ES87302644T patent/ES2001147A4/es active Pending
Also Published As
Publication number | Publication date |
---|---|
NZ219771A (en) | 1990-10-26 |
JPS62289525A (ja) | 1987-12-16 |
IL81990A0 (en) | 1987-10-20 |
EP0240257A2 (en) | 1987-10-07 |
GB8707256D0 (en) | 1987-04-29 |
AU7062187A (en) | 1987-10-01 |
GB2193091A (en) | 1988-02-03 |
ES2001147A4 (es) | 1988-05-01 |
EP0240257A3 (en) | 1990-05-09 |
DE240257T1 (de) | 1988-08-11 |
GB2193091B (en) | 1990-10-24 |
GB8607749D0 (en) | 1986-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR860342B (en) | 11b- phenyl-gonane their preparation and pharmaceutical preparations containing them | |
NZ222103A (en) | 9-alpha-hydroxy steroids and pharmaceutical preparations containing them | |
HU906229D0 (en) | Medical preparations | |
GB8610572D0 (en) | Pharmaceutical preparation | |
CS419991A3 (en) | Pharmaceutical preparations | |
GB8421706D0 (en) | Pharmaceutical preparations | |
NZ220020A (en) | 1-hydroxy-2-pyridones and pharmaceutical composition | |
CS8700282A2 (en) | Nicorandil-containing stable pharmaceutical | |
EP0207451A3 (en) | Pharmaceutical preparations | |
ZA872167B (en) | Compounds and pharmaceutical preparations having calcium-regulatory activity | |
ZA852279B (en) | Pharmaceutical preparations | |
GB8520189D0 (en) | Pharmaceutical preparations | |
GB2174004B (en) | Pharmaceutical tablet preparations | |
SG75192G (en) | Rodent-repellent microcapsules and preparations thereof | |
ZA878257B (en) | Analgesic preparations | |
ZA885969B (en) | Pharmaceutical preparations for external use | |
GB8721313D0 (en) | Pharmaceutical preparation | |
ZA847975B (en) | Beta-elemonic acid and pharmaceutical preparations | |
ZA875281B (en) | Zylometzoline-containing pharmaceutical preparations | |
GB8506388D0 (en) | Pharmaceutical preparations | |
IE873302L (en) | Pharmaceutical preparations | |
IE861311L (en) | Pharmaceutical preparations | |
GB8630926D0 (en) | Pharmaceutical preparations | |
GB8603271D0 (en) | Pharmaceutical preparations | |
ZA864716B (en) | Pharmaceutical preparations |